Growth factors and apoptosis in neonatal ureteral obstruction

Journal of the American Society of Nephrology

Volumn 7, Issue 8, 1996, Pages 1098-1105

  Chevalier, Robert L ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Apoptosis; Clusterin; Renal development; Transforming growth factor beta 1; Ureteral obstruction

Indexed keywords

ANGIOTENSIN; CLUSTERIN; EPIDERMAL GROWTH FACTOR; GLYCOPROTEIN; GROWTH FACTOR; ONCOPROTEIN; PROTEIN BCL 2; RENIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; BIRTH DEFECT; CONTROLLED STUDY; GUINEA PIG; KIDNEY DEVELOPMENT; KIDNEY FAILURE; KIDNEY INJURY; NEWBORN; NEWBORN DISEASE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; URETER OBSTRUCTION; VASOCONSTRICTION;

EID: 0030377608     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Najarian JS, Almond PS, Gillingham KJ, et al.: Renal transplantation in the first five years of life. Kidney Int 1993;44:S40-S44.
2. Taki M, Goldsmith DI, Spitzer A: Impact of age on effects of ureteral obstruction on renal function. Kidney Int 1983;24:602-609.
3. Chevalier RL, Gomez RA, Jones CA: Developmental determinants of recovery after relief of partial ureteral obstruction. Kidney Int 1988;33:775-781.
4. Chevalier RL, Sturgill BC, Jones CE, Kaiser DL: Morphologic correlates of renal growth arrest in neonatal partial ureteral obstruction. Pediatr Res 1987;21:338-346.
5. Chevalier RL, Peach MJ: Hemodyamic effects of enalapril on neonatal chronic partial ureteral obstruction. Kidney Int 1985;28:891-898.
6. Gomez RA, Lynch KR, Sturgill BC, et al.: Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol 1989;257:F850-F858.
7. El-Dahr SS, Gomez RA, Gray MS, Peach MJ, Carey RM, Chevalier RL: In situ localization of renin and its mRNA in neonatal ureteral obstruction. Am J Physiol 1990;258: F854-F862.
8. Norwood VF, Carey RM, Geary KM, Jose PA, Gomez RA, Chevalier RL: Neonatal ureteral obstruction stimulates recruitment of renin-secreting renal cortical cells. Kidney Int 1994;45:1333-1339.
9. Yoo KH, Norwood VF, Chevalier RL: Regulation of angiotensin II AT1 and AT2 receptors in neonatal unilateral ureteral obstruction [Abstract]. J Am Soc Nephrol 1995; 6:1035A.
10. El-Dahr SS, Gee J, Dipp S, Hanss BG, Vari RC, Chao J: Upregulation of renin-angiotensin system and down-regulation of kallikrein in obstructive nephropathy. Am J Physiol 1993;264:F874-F881.
11. Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomez RA: Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 1995;269: F110-F115.
12. Chung KH, Gomez RA, Chevalier RL: Regulation of renal growth factors and clusterin by angiotensin AT1 receptors during neonatal ureteral obstruction. Am J Physiol 1995;268:F1117-F1123.
13. Kim S, Ohta K, Hamaguchi A, et al.: Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kidney Int 1994;46: 1346-1358.
14. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-Beta expression in rat glomerular mesangial cells. J Clin Invest 1994;93:2431-2437.
15. Johnson RJ, Alpers CE, Yoshimura A, et al.: Renal injury from angiotensin II-mediated hypertension. Hypertension (Dallas) 1992;19:464-474.
16. Giachelli CM, Pichler R, Lombardi D, et al.: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 1994;45:515-524.
17. Haralambous-Gasser A, Chan D, Walker RG, Powell HR, Becker GJ, Jones CL: Collagen studies in newborn rat kidneys with incomplete ureteric obstruction. Kidney Int 1993;44:593-605.
18. Claesson G, Josephson S, Robertson B: Experimental partial ureteric obstruction in newborn rats: IV. Do the morphological effects progress continuously? J Urol 1983;130:1217-1222.
19. Josephson S, Grossmann G: Partial ureteric obstruction in the pubescent rat. II. Long-term effects on the renal morphology. Urol Int 1991;47:126-130.
20. Chung KH, Chevalier RL: Arrested development of the neonatal kidney following chronic ureteral obstruction. J Urol 1996;155:1139-1144.
21. Schreiner GF, Harris KPG, Purkerson ML, Klahr S: Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int 1991;34: 487-493.
22. Diamond JR, Kees-Folts D, Ricardo SD, Pruznak A, Eufemio M: Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 1995;146:1455-1466.
23. Claesson G, Josephson S, Robertson B: Experimental partial ureteric obstruction in newborn rats. IV. Do the morphological effects progress continuously? J Urol 1983;130:1217-1222.
24. Carey AV, Carey RM, Gomez RA: Expression of Alpha-smooth muscle actin in the developing kidney vasculature. Hypertension 1992;19[Suppl 2]:II168-II175.
25. Schmitt-Graff A, Desmouliere A, Gabbiani G: Heterogeneity of myofibroblast pehnotypic features: An example of fibroblastic cell plasticity. Virchows Archiv 1994;425: 3-24.
26. Raaberg L, Nexo E, Mikkelsen JD, Poulsen SS: Immunohistochemical localisation and developmental aspects of epidermal growth factor in the rat. Histochemistry 1988;89:351-356.
27. Wolf G, Neilson EG: Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 1990;259:F768-F777.
28. Taub M, Wang Y, Szczesny TM, Kleinman HK: Epidermal growth factor or transforming growth factor a is required for kidney tubulogenesis in matrigel cultures in serum-free medium. Proc Natl Acad Sci USA 1990;87: 4002-4006.
29. Yoo KH, Thornhill BA, Chevalier RL: Tubular epithelial cell epidermal growth factor receptor polarity is altered by ureteral or single nephron obstruction [Abstract]. J Am Soc Nephrol 1996, in press.
30. Orellana SA, Sweeney WE, Neff CD, Avner ED: Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Kidney Int 1995;47:490-499.
31. Roberts AB, McCune BK, Sporn MB: TGF-B: Regulation of extracellular matrix. Kidney Int 1992;41:557-559.
32. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 1995;47:1285-1294.
33. Gobe GC, Axelsen RA: Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Lab Invest 1987;56:273-281.
34. Kennedy WA II, Stenberg A, Lackgren G, Hensle TW, Sawczuk IS: Renal tubular apoptosis after partial ureteral obstruction. J Urol 1994;152:658-664.
35. Chevalier RL, Chung KH, Smith CD, Ficenec M, Gomez RA: Renal apoptosis and clusterin following ureteral obstruction: The role of maturation. J Urol 1996, in press.
36. Connor J, Buttyan R, Olsson CA, D'Agati V, O'Toole K, Sawczuk IS: SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis. Kidney Int 1991;39:1098-1103.
37. Harding MA, Chadwick LJ, Gattone VH II, Calvet JP: The SGP-2 gene is developmentally regulated in the mouse kidney and abnormally expressed in collecting duct cysts in polycystic kidney disease. Dev Biol 1991;146: 483-490.
38. Blashuk O, Burdzy K, Fritz IB: Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J Biol Chem 1983;258:7714-7720.
39. Silkensen JR, Skubitz KM, Skubitz APN, et al.: Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells. J Clin Invest 1995;96:2646-2653.
40. Buttyan R, Olsson CA, Pintar J, et al.: Induction of the TRPM-s gene in cells undergoing programmed death. Mol Cell Biol 1989;9:3473-3481.
41. Wong P, Pineault J, Lakins J, et al.: Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis. J Biol Chem 1993;268: 5021-5031.
42. French LE, Wohlwend A, Sappino AP, Tschopp J, Schifferli JA: Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J Clin Invest 1994;93:877-884.
43. Correa-Rotter R, Hostetter TH, Manivel JC, Eddy AA, Rosenberg ME: Intrarenal distribution of clusterin following reduction of renal mass. Kidney Int 1992;41:938-950.
44. Gobe GC, Buttyan R, Wyburn KRL, Etheridge MR, Smith PJ: Clusterin expression and apoptosis in tissue remodeling associated with renal regeneration. Kidney Int 1995;47:411-420.
45. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993;75:229-240.
46. Chevalier RL, Smith CD, Krajewski S, Reed JC: Renal apoptosis following unilateral uretaral obstruction is associated with suppression of bcl-2 [Abstract]. J Am Soc Nephrol 1995;6:976A.
47. Hockenbery DM: bcl-2 in cancer, development and apoptosis. J Cell Sci 1994;107[Suppl 18]:51-55.
48. Sandstrom PA, Pardi D, Tebbey PW, et al.: Lipid hydroperoxide-induced apoptosis: Lack of inhibition by Bcl-2 over-expression. FEBS (Fed Eur Biol Soc) Lett 1995;66:70.
49. Fetterman GH, Ravitch MM, Sherman FE: Cystic changes in fetal kidneys following ureteral ligation: Studies by microdissection. Kidney Int 1974;5:111-121.
50. Graham PC, Lindop GBM: The anatomy of the renin-secreting cell in adult polycystic kidney disease. Kidney Int 1988;33:1084-1090.
51. Gattone VH, Andrews GK, Niu Fu-Wen, Chadwick LJ, Klein RM, Calvet JP: Defective epidermal growth factor gene expression in mice with polycystic kidney disease. Dev Biol 1990;138:225-230.
52. Woo D: Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 1995;333:18-25.
53. Rosenberg ME, Manivel JC, Carone FA, Kanwar YS: Genesis of renal cysts is associated with clusterin expression in experimental cystic disease. J Am Soc Nephrol 1995;5:1669-1674.
54. Morrissey J, McCracken R, Ishidoya S, Klahr S: Regulation of PKD1 expression during ureteral obstruction [Abstract]. J Am Soc Nephrol 1995;6:703A.